C
CardiacSense
Develops optical-based, noninvasive sensor technology for the medical market
About CardiacSense
CardiacSense is an innovative startup specializing in wearable medical technology, specifically designed to monitor heart health. The company's flagship product is a medical-grade watch that continuously tracks heart rate and detects arrhythmias, such as atrial fibrillation (AF). This watch has demonstrated high accuracy, with clinical studies showing 99% sensitivity and 99% specificity in distinguishing AF from normal heart rhythms.
Read full description
CardiacSense primarily serves healthcare professionals, patients, and telemedicine providers. The company operates in the global healthcare market, with regulatory approvals in regions like Israel and the European Union, and significant contracts in countries such as India.
The business model of CardiacSense revolves around the sale of its medical watches to healthcare providers and institutions. These entities then use the watches for remote patient monitoring and telemedicine services. By providing continuous and accurate heart monitoring, CardiacSense helps healthcare providers offer better care to patients, especially those with chronic heart conditions.
CardiacSense generates revenue through direct sales of its medical watches and potentially through partnerships with healthcare organizations and telemedicine companies. The company has secured substantial contracts, such as a $32.4 million deal in India, which underscores its growing market presence and the demand for its technology.
In summary, CardiacSense is a key player in the wearable medical technology market, offering advanced heart monitoring solutions that cater to healthcare providers and patients worldwide. Its business model focuses on sales and partnerships, ensuring a steady revenue stream as it expands its market reach.
At a glance
- Status
- Operational
- Founded
- 2009
- Headquarters
- Caesarea, Israel
- Employees
- 39
- Open positions
- None listed
- Dealroom signal
- 72.2/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences
- Technology
- Artificial Intelligence, Hardware, Deep Tech, Machine Learning, Nanotech, Computer Vision, Connected Device, Recognition Technology, IoT InternetOfThings
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2022 | $9.3M | $37M | Undisclosed | — |
| SERIES AEquity / VC | Feb 2021 | $1.5M | $6M | Undisclosed | — |
Growth signals
Latest recorded traffic for CardiacSense is 8.4K monthly website visits, up 29.2% over the last three months. CardiacSense's team declined 2.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
European Innovation Council
Together
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about CardiacSense on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CardiacSense’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.